<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with ischemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> have an increased risk for <z:hpo ids='HP_0004308'>ventricular arrhythmia</z:hpo>, since <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> can be the substrate for re-entrant <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Contrast-enhanced cardiac magnetic resonance imaging (CMR) has proven to reliably quantify <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Aim of our study was to evaluate correlations between functional and contrast-enhanced CMR findings and spontaneous ventricular tachy-<z:hpo ids='HP_0011675'>arrhythmias</z:hpo> in patients with ischemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> who underwent implantable cardioverter-defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) therapy </plain></SENT>
<SENT sid="3" pm="."><plain>Forty-one patients with ischemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> and indication for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy underwent cine and late <z:chebi fb="0" ids="33375">gadolinium</z:chebi> enhancement CMR for quantification of left ventricular volumes, function and scar tissue before subsequent implantation of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> device </plain></SENT>
<SENT sid="4" pm="."><plain>During a follow-up period of 1184 ± 442 days 68 monomorphic and 14 polymorphic types of <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> (VT) could be observed in 12 patients </plain></SENT>
<SENT sid="5" pm="."><plain>Patients with monomorphic VT had larger scar volumes (25.3 ± 11.3 vs. 11.8 ± 7.5% of myocardial mass, P &lt; 0.05) than patients with polymorphic VT </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> involved more segments in the LAD perfusion territory (86 vs. 20%, P &lt; 0.05) than in patients with polymorphic VT </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with spontaneous monomorphic VT during the long-term follow-up period had more infarcted tissue, which was more often present in the LAD perfusion territory than patients with polymorphic events </plain></SENT>
<SENT sid="8" pm="."><plain>These data strengthen the diagnostic benefit of CMR in patients with ischemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>CMR may be used for better risk stratification in patients with ischemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> undergoing <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy </plain></SENT>
</text></document>